Daily FNArena News

ATW’s Jerry Simmons explains how and why his technical analysis suggests equity markets might be poised for a larger correction.

Bradken fell short of market expectations with its interim result but maintained full year guidance.

Once hailed as a reliable lead indicator for bulk commodity prices, the Baltic Dry Index appears to have lost the plot.

Charlie Chartchecker finds US equities continue to attract support and sellers are nowhere to be found.

Big Pharma are picking up the pace of acquisitions in the biotech sector and Southern Cross equities suggests this offers some upside to the Australian plays.

BTIG Chief Market Strategist Mike O’Rourke explains why he believes equities will start encountering headwinds.

Oil prices have again pushed above the US$100 per barrel mark but in the view of Barclays Capital this is unlikely to derail the economic recovery or US consumption.

Market analysts and strategists are reviewing their preferences between commodities and “others” for the year ahead.

Supply issues persist to help push spot uranium higher yet again last week.

Equinox Minerals has announced a material resource upgrade at its Lumwana copper project and with scope for more to come brokers are positive on the stock.